Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 17 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

18%

3 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
2(40.0%)
N/A
2(40.0%)
Phase 3
1(20.0%)
5Total
Phase 4(2)
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT06795646Not Yet Recruiting

Clinical Classification of MAFLD Based Liver Biopsy

Role: collaborator

NCT04546360Completed

Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

Role: collaborator

NCT06535048Active Not Recruiting

Impact of Fatty Liver on Hepatitis B Therapy

Role: lead

NCT05937178Recruiting

Real-world Study Optimizing Nucleotide-analogues

Role: collaborator

NCT04939441Phase 4Unknown

Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)

Role: collaborator

NCT04639323Unknown

Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)

Role: collaborator

NCT04307264Completed

CHESS Criteria for Varices Screening in Compensated Advanced Chronic Liver Disease (CHESS2001/APPHA2001)

Role: collaborator

NCT04883177Completed

Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

Role: collaborator

NCT05100485Completed

Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)

Role: collaborator

NCT05360420Not ApplicableUnknown

Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical Procedure

Role: collaborator

NCT03603977Recruiting

Simplified Treatment of Anti-retrovirus in China (C-STAR)

Role: collaborator

NCT03577938Not ApplicableCompleted

Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment

Role: collaborator

NCT04543643Phase 3Unknown

Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis

Role: lead

NCT03990753Unknown

Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901)

Role: collaborator

NCT04028323Phase 4Unknown

Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)

Role: collaborator

NCT04975477Unknown

CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102)

Role: collaborator

NCT04329559Completed

COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study

Role: collaborator

All 17 trials loaded